Primary and secondary results of LUMINESCE, a Phase 3 study of interleukin-6 signaling inhibition by satralizumab in generalized myasthenia gravis
To determine if IV glutathione is a truly efficacious symptomatic therapy for Parkinsons, larger, randomized, placebo-controlled trials need to be done
Global pandemics interconnected - obesity, impaired metabolic health and COVID-19
Consequently, you can only buy BPC-157 for scientific and educational research, not for human consumption
Cons: 90-count (fewer than NOW or Nutricost), premium practitioner pricing, NAC only (no supporting cofactors)
Y.PanziliusE.KobayashiS.IngoldI.et al (2017)